A Study of Bevacizumab, Carboplatin, and Paclitaxel or Pemetrexed With or Without Atezolizumab in Chemotherapy-Naïve Patients With Stage IV Non-Squamous Non-Small Cell Lung Cancer (IMpower151)
Conditions
- Carcinoma, Non-Small-Cell Lung
Interventions
- DRUG: Atezolizumab
- DRUG: Placebo
- DRUG: Bevacizumab
- DRUG: Paclitaxel
- DRUG: Pemetrexed
- DRUG: Carboplatin
Sponsor
Hoffmann-La Roche